CELIX PHARMA LTD: UK Public Sector Contracts Won & Awards
SME·London·Greater London·Main market: Pharmaceutical products
Official UK PPONPDZD-6425-PVYX
Procedures with an award1828 award recordsPublic authorities5named on published awardsAttributable award value£181knet · on 1 of 28 award records · single-supplier, no ceilingsLast 12 months12awards · 11 in the prior 24 months · last 27 Aug 2026Contracts ending ≤18 months3end date published on 5 of 28 awardsDelivery regions12most often Nationwide (UK)
Where they win
27 lot-level observations (17 awarded lots, 63%, plus 10 envelope awards without lot links; pending awards included) · top CPV classes
3360 Pharmaceutical products26 observations · 100% · 16 lots + 10 envelopeAttributable award value£181kSum of published VAT-exclusive values on 1 of 28 award records — only awards to this supplier alone, framework / DPS ceilings excluded; the award’s own value, else its contract’s; the five largest make 100%. Not turnover. Largest rows below.
| Largest published awards | Authority | Awarded | Term | Published value |
|---|---|---|---|---|
| Transitional Drugs 3 | Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts | — | — | £180,520 † |
Where they deliver
ITL1 delivery regions on the notice · 18 of 18 awarded procedures publish one · a procedure with several regions counts in each
Nationwide (UK)8 procedures · 44%
North East England4 procedures · 22%
North West England4 procedures · 22%
East Midlands4 procedures · 22%
West Midlands4 procedures · 22%
East of England4 procedures · 22%
South East England4 procedures · 22%
South West England4 procedures · 22%
Bidding record
Procurement Act 2023 award notices name every bidder · 4 notices name this supplier since 30 Jan 2026 · observed bids, not an estimate
Contract contests0 won · 0 lostFewer than three decided contests — no rate is claimed.
Framework / DPS places4 of 4Admissions to a panel or dynamic market are counted apart: nearly every compliant bidder is appointed, so they say nothing about winning work.
Authorities bid for1
| Notice | Authority | Outcome | Bidders | Published |
|---|---|---|---|---|
| NHS National Generic Pharmaceuticals - Wave 16a | NHS England | appointed | 125 | 1 Sept 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | NHS England | appointed | 14 | 24 Apr 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | NHS England | appointed | 118 | 26 Feb 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | NHS England | appointed | 8 | 30 Jan 2026 |
Source: bids.details[].tenderers on Procurement Act 2023 notices (from 2025). PCR 2015 notices name no bidders, so earlier contests are invisible here. Latest ten notices shown.
Who they sell to
Authorities named on this supplier’s published awards · ranked by distinct procedures · award records explode on framework and DPS panels
Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
- NHS & health 67% (18 awards)
- Central government 33% (9 awards)
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 12 | 66.7% | 17 | 27 Aug 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | 3 | 16.7% | 8 | 30 Mar 2026 |
| Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts | 1 | 5.6% | 1 | 14 May 2025 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 1 | 5.6% | 1 | 26 Sept 2023 |
| Velindre University NHS Trust | 1 | 5.6% | 1 | 4 Jun 2026 |
Share = of the 18 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts ending
Published end dates only · 5 of 28 awards carry one · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Lot 1 - CM/PHG/23/5699/01 Oral (plus non-parenteral) products | 31 May 2027 | £17,727,000 |
| Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin | 30 Sept 2027 | £25,881,000 |
| Lot 1 - CM/TNS/25/5736 Nintedanib and Dalbavancin | 30 Sept 2027 | £14,758,000 |
Recent awards
Latest 28 of 28 award records naming this supplier
| Award / procedure | Authority | Awarded | Award value |
|---|---|---|---|
| Range of Generic Cancer Medicines (single supplier) | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Not published | Not published |
| Wave 15a - Orals (plus non-parenteral) Products (all regions) | NHS England | Not published | Not published |
| Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets | NHS England | Not published | Not published |
| Dimethyl fumarate, Teriflunomide, Trabectedin | NHS England | Not published | Not published |
| NP39723a Bexarotene | The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | Not published | Not published |
| Lot 1 - CM/PHG/22/5657/02 Hospital Only Products: DLN & DNW: | NHS England | Not published | Not published |
| Lot 1 - CM/PHG/21/5637/00 Transition Products | NHS England | Not published | Not published |
| Hereditary Angioedema. Lot 5 - Icatibant | NHS England | Not published | Not published |
Data coverage & method
- Source: Find a Tender OCDS award and contract releases. An award record is one award × this supplier; a procedure can carry many (panels, call-offs).
- Market observations are awarded lots, or one envelope award when the notice publishes no lot links. Region = delivery ITL1 on the notice, not the supplier’s registered address.
- Authority type: official OCDS UK contracting-authority type when the notice publishes one; otherwise a Tenderline name/id class; otherwise “not classified”. Purchasing hubs with no published type stay unclassified.
- Published value attributable to this supplier alone: £181k across single-supplier awards, framework / DPS ceilings excluded. Coverage is partial and the figure is not turnover, so it is not shown as a headline.
- Contract end dates: published on 5 of 28 awards; 3 end within 18 months.
- Never shown: contact details, reliability or payment scores, affiliations, predicted wins.
Identifiers consolidated into this page (7 historical Find a Tender publication identifiers)
Official notices referenced this supplier under these publication identifiers. Alias URLs are not separate pages.
Canonical page id: GB-PPON:PDZD-6425-PVYX